2013;304:G111727
According to the American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) Obesity Clinical Practice Guidelines, weight loss medications should be considered as an adjunct to lifestyle therapy in all patients with T2DM as needed for weight loss sufficient to improve glycemic control, lipids, and blood pressure
It is FDA-approved for type 2 diabetes treatment only but can be prescribed off-label for weight loss
Its potential health benefits have gained growing scientific interest, with reported effects including hypocholesterolemic, hepatoprotective, antidiabetic, anti-inflammatory, anti-obesity, antiproliferative, cytotoxic, and antioxidant actions 1
Ongoing totals begin at $348 and can reach $598 on the live price page, or $648 if the separate $499 Zepbound high-dose page applies